Every Form 4 that Upexi, Inc. (UPXI) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A Form 4 covers the transactions officers, directors and large holders report, so if you follow UPXI and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full UPXI filings page.
Salkind Gene reported acquisition or exercise transactions in this Form 4 filing.
Upexi, Inc. director Gene Salkind received a grant of 100,000 shares of restricted common stock under the company’s 2019 Incentive Stock Plan, as amended. The award vests in four equal quarterly installments, with full vesting on July 1, 2027, subject to continued service. After this grant, Salkind directly holds 318,750 common shares.
Dugan Lawrence reported acquisition or exercise transactions in this Form 4 filing.
Upexi, Inc. director Dugan Lawrence received a grant of 100,000 shares of restricted common stock as equity compensation. The award was issued under the company’s 2019 Incentive Stock Plan and vests in four equal quarterly installments, with full vesting on July 1, 2027, subject to continued service. Following this grant, Lawrence directly holds 216,389 Upexi common shares.
Upexi, Inc. reported an equity compensation grant to Chief Strategy Officer Brian Benjamin Rudick. He acquired 400,000 shares of common stock as restricted stock under the 2019 Incentive Stock Plan, bringing his direct holdings to 1,238,597 shares. The award vests in four equal installments between October 1, 2026 and July 1, 2027, subject to continued service.
MARSHALL ALLAN reported acquisition or exercise transactions in this Form 4 filing.
Upexi, Inc. reported that Chief Executive Officer Marshall Allan received a grant of 2,000,000 shares of restricted common stock under the 2019 Incentive Stock Plan. The award vests in four equal installments on October 1, 2026, January 1, 2027, April 1, 2027 and July 1, 2027, subject to continued service, bringing his direct holdings to 6,046,261 shares.
Norstrud Andrew James reported acquisition or exercise transactions in this Form 4 filing.
Upexi, Inc. reported that Chief Financial Officer and director Andrew James Norstrud received a grant of 400,000 shares of restricted common stock under the company’s 2019 Incentive Stock Plan. These shares vest in four equal installments on October 1, 2026, January 1, 2027, April 1, 2027 and July 1, 2027, subject to continued service. Following this award, Norstrud beneficially owns 1,049,138 shares of Upexi common stock.
Upexi, Inc. disclosed insider share activity by Chief Executive Officer and Director Allan Marshall. On 10/01/2025, he was granted 1,600,000 shares of common stock at $0 under the company’s Equity Incentive Plan, vesting quarterly in equal installments over 12 months beginning October 1, 2025. He also made open-market purchases of 100,000 shares at $2.07 on 12/15/2025 and 50,000 shares at $2.07 on 12/16/2025. Following these transactions, Marshall beneficially owns 3,996,261 shares of Upexi common stock directly.
Upexi, Inc. (UPXI) director reports open-market share purchase. Director Gene Salkind filed a Form 4 disclosing the purchase of 50,000 shares of Upexi common stock on 11/20/2025 at a price of $2.55 per share. The transaction was coded as a purchase and was executed on the open market.
After this transaction, Salkind is reported to beneficially own 218,750 shares of Upexi common stock through an indirect position. The filing notes that the shares are held via the Marital Trust GST subject U/W/O Leopold Salkind, for which Gene Salkind serves as trustee, so the holdings are treated as indirect ownership.
Upexi, Inc. (UPXI) reported that Chief Financial Officer and director Andrew Norstrud acquired 240,000 shares of common stock on 10/01/2025 in a transaction reported on Form 4. The shares were granted at a stated price of $0 per share as an equity award.
The filing notes that these shares were granted under the issuer's Equity Incentive Plan and are scheduled to vest quarterly in equal installments over 12 months beginning October 1, 2026. Following this grant, Norstrud beneficially owns 649,138 shares of common stock, held directly.
Upexi, Inc. (UPXI) reported insider share purchases by director Gene Salkind. On 11/17/2025, he bought a total of 200,000 shares of common stock in open-market transactions.
He acquired 100,000 shares directly at $2.65 per share, bringing his directly owned stake to 569,470 shares. He also acquired another 100,000 shares at $2.81 per share through the Marital Trust GST subject U/W/O Leopold Salkind, where he serves as trustee, resulting in 168,750 shares of indirect beneficial ownership.
The filing classifies him as a director of Upexi and treats the trust-held shares as indirect ownership because they are controlled in his role as trustee.